BioLife Solutions (BLFS)
(Delayed Data from NSDQ)
$25.57 USD
-0.71 (-2.70%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $25.57 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, BioLife Solutions, Inc. has a PEG ratio of 23.79 compared to the Medical - Products industry's PEG ratio of 2.11.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BLFS 25.57 -0.71(-2.70%)
Will BLFS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BLFS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BLFS
Are Medical Stocks Lagging Bayer (BAYRY) This Year?
Does BioLife Solutions (BLFS) Have the Potential to Rally 25.6% as Wall Street Analysts Expect?
BLFS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks Industry Outlook Highlights Envista, BioLife Solutions, InfuSystems and MariMed
4 Medical Product Stocks to Watch From a Challenging Industry
BioLife Solutions (BLFS) Upgraded to Strong Buy: Here's Why
Other News for BLFS
Fell Below 20 Day Moving Average appears for BLFS after 2.7% move
Is BLFS set to rally? Crossed Above 20 Day Moving Average shows up after gaining 2.72%
Fell Below 20 Day Moving Average appears for BLFS after 1.52% move
Is BLFS set to rally? 20 Day Moving Average Support shows up after climbing 0.7%
Insider Sell: Sarah Aebersold Sells Shares of BioLife Solutions Inc (BLFS)